Exploration of the Relationship of Reduction in HbA1c and Body Weight by Dapagliflozin in Patients With T2DM: Pooled Analysis of 5 Clinical Trials

被引：0
|
作者：
Hardy, Elise
Salsali, Afshin
Wessman, Catrin
Wei, Li
Mansfield, Traci
Parikh, Shamik
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
987-P
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin (DAPA) Reduces HbA1c in Asian Patients with T2DM after Metformin (MET) Failure
    Yang, Wenying
    Han, Ping
    Liu, Beijing
    Mansfield, Traci
    T'Joen, Caroline L.
    Iqbal, Nayyar
    Ptaszynska, Agata
    DIABETES, 2014, 63 : A279 - A279
  • [2] Individualized HbA1c targets in elderly patients with T2DM
    Linda Koch
    Nature Reviews Endocrinology, 2013, 9 (8) : 440 - 440
  • [3] Factors associated with HbA1c reduction in Asian patients with T2DM: an analysis of the FINE Asia registry
    Kiat, K. Tan Eng
    Ji, L.
    Suastika, K.
    Wang, J.
    Wang, E.
    Lin, J.
    Tsai, S. -T.
    DIABETOLOGIA, 2011, 54 : S428 - S428
  • [4] Clinical Response (HbA1c ≥1% and/or Body Weight ≥5% Reduction) to Semaglutide by Baseline HbA1c and Body Weight in the SUSTAIN Program
    Aroda, Vanita R.
    Larsen, Julie F.
    Ostoft, Signe Harring
    Rea, Rosangela R.
    Sugimoto, Danny
    Ziegler, Uwe
    Vilsboll, Tina
    DIABETES, 2019, 68
  • [5] An average HbA1C of <7.0 is achievable in patients with T2DM
    Hood, RC
    DIABETES, 2002, 51 : A485 - A485
  • [6] HBA1C REDUCTION WITH DIGITAL HEALTH DEVICES IN TYPE 2 DIABETES (T2DM): A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lee, F.
    Han-Burgess, E.
    Kennedy, A.
    Serafini, P.
    Pourrahmat, M. M.
    Breznen, B.
    VALUE IN HEALTH, 2023, 26 (06) : S297 - S297
  • [7] Effect of LSG on HbA1c Levels in T2DM Patients at One Year
    不详
    OBESITY SURGERY, 2009, 19 (08) : 1005 - 1006
  • [8] Modelling HbA1c Trajectory in Patients with Type 2 Diabetes Mellitus (T2DM)
    Mcewan, Phil
    Fellows, Jonathan
    Yapp, Rhiannon
    Bergenheim, Klas
    Qin, Lei
    Varol, Nebibe
    Bennett, Hayley
    Gordon, Jason
    DIABETES, 2016, 65 : A322 - A322
  • [9] Treatment Progression and Impact of HbA1C in Type 2 Diabetes (T2DM) Patients
    Dibello, Julia R.
    Levy, Brian
    Mehra, Maneesha
    DIABETES, 2010, 59 : A623 - A624
  • [10] Semaglutide reduces HbA1c and body weight across baseline HbA1c subgroups in the SUSTAIN 1-5 clinical trials
    Bain, S.
    Araki, E.
    Desouza, C.
    Garg, S.
    Rose, L.
    Tsoukas, G.
    Bergan, E.
    Karsbol, J. Derving
    DeVries, J.
    DIABETOLOGIA, 2017, 60 : S375 - S375
12345